Yakult Honsha Co.,Ltd. Share Price

Equities

2267

JP3931600005

Food Processing

Market Closed - Japan Exchange 11:30:00 26/04/2024 am IST 5-day change 1st Jan Change
3,058 JPY -0.62% Intraday chart for Yakult Honsha Co.,Ltd. +2.67% -3.44%

Financials

Sales 2024 * 506B 3.2B 266B Sales 2025 * 519B 3.28B 273B Capitalization 937B 5.91B 493B
Net income 2024 * 50.94B 322M 26.82B Net income 2025 * 52.76B 333M 27.78B EV / Sales 2024 * 1.53 x
Net cash position 2024 * 162B 1.02B 85.28B Net cash position 2025 * 183B 1.15B 96.19B EV / Sales 2025 * 1.45 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
17.7 x
Employees 29,880
Yield 2024 *
1.8%
Yield 2025 *
1.87%
Free-Float 71.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.62%
1 week+2.67%
Current month-1.96%
1 month-2.30%
3 months-4.76%
6 months-14.00%
Current year-3.44%
More quotes
1 week
3 023.00
Extreme 3023
3 115.00
1 month
2 920.50
Extreme 2920.5
3 152.00
Current year
2 920.50
Extreme 2920.5
3 334.00
1 year
2 920.50
Extreme 2920.5
5 215.00
3 years
2 645.00
Extreme 2645
5 215.00
5 years
2 407.50
Extreme 2407.5
5 215.00
10 years
2 252.50
Extreme 2252.5
5 215.00
More quotes
Managers TitleAgeSince
President 72 01/74/01
Chief Administrative Officer 72 01/77/01
Director/Board Member - -
Members of the board TitleAgeSince
Director/Board Member 78 01/09/01
Chief Administrative Officer 72 01/77/01
President 72 01/74/01
More insiders
Date Price Change Volume
26/24/26 3,058 -0.62% 1,127,500
25/24/25 3,077 -0.23% 762,200
24/24/24 3,084 -0.55% 1,066,000
23/24/23 3,101 0.00% 1,159,600
22/24/22 3,101 +4.11% 1,989,400

Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST

More quotes
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
3,058 JPY
Average target price
3,529 JPY
Spread / Average Target
+15.40%
Consensus